Cycle Pharmaceuticals (Cycle) has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of ...

Cycle Pharmaceuticals (Cycle) has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of their treatment plan. It can be challenging for patients with PKU, or ...

Increased cortisol levels. Other studies have indicated that consuming aspartame can increase cortisol levels, which changes ...

Learn more about the benefits and risks of L-tyrosine supplements, the “over-the-counter Adderall.” ...

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

"BioMarin’s trial for phenylketonuria therapy meets primary efficacy endpoint" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data. PKU is a rare ...

Also known as PAH deficiency, phenylketonuria is a genetic condition. Credit: bangoland / Shutterstock. BioMarin Pharmaceutical has reported that the multi-centre Phase III PEGASUS trial of Palynziq ...

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals (Cycle) has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of their treatment plan. It can be challenging ...